Davita company profile
Company profile
Davita has 78,000 employees and is headquartered in Denver, United States.
Based in Denver, Colorado, DaVita Inc. has existed since 1994 and works in dialysis. Its core business is treating patients whose kidneys have lost their function, delivered mainly through outpatient dialysis centers in the United States, with hospital inpatient and home-based hemodialysis also offered. Alongside these treatments, the group runs clinical laboratories serving dialysis patients, provides management and administrative services to outpatient dialysis centers, and offers integrated care, disease management and physician services. It also holds a transplant software business and conducts clinical research programs.
In the fiscal year ended December 2025, DaVita reported revenue of USD 13.6 billion, up 6.5% from the previous year, and net income of USD 746.8 million. The company had 78,000 employees, and its headquarters is in Denver.
Company facts
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Headquarters
- 2000 16th Street, 80202, Denver
- Employees
- 78,000
- Chief executive
- Javier Rodriguez
- Founded
- 1994
- Fiscal year
- January - December
- Listing
- DVA · NYSE
- Indices
- S&P 500
- Currency
- USD
- ISIN
- US23918K1088
- Website
- davita.com
Davita and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| DavitaDVA | United States | $10.13B | 78,000 | 15.2% | 12.2 |
| Ensign GroupENSG | United States | $10.29B | 46,000 | 8.8% | 26.2 |
| Universal Health ServicesUHS | United States | $10.34B | 102,000 | 10.9% | 7.51 |
| Encompass HealthEHC | United States | $13.11B | 29,875 | 18.4% | 21.4 |
| Tenet HealthcareTHC | United States | $20.95B | 77,000 | 19.1% | 7.68 |
| HCA HealthcareHCA | United States | $99.34B | 230,000 | 15.3% | 15.8 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
